Biomarkers for Diabetes

Biomarker”, are called “molecular marker” or a “signature molecule”. These viewed as direct or indirect markers of the extent of disease as they lay outside in a casual way. HbA1c is considered a biomarker for a risk factor that is for retinopathy, nephropathy and other vascular diseases. Biomarkers enable preventive measures to be applied at the subclinical stage and the responses to preventive or therapeutic measures to be monitored. Cases over the past two decades have yielded sample sets, mostly blood products and urine from a large category of patients with both type 1 and type 2 diabetes.


  • Carbonyl stress
  • Pulse wave analysis
  • Auto fluorescence
  • Biomarkers of vascular function in diabetes

Related Conference of Biomarkers for Diabetes

June 20-21, 2018

27th European Diabetes Congress

| Rome, Italy
July 16-17, 2018 Sydney, Australia

20th Asia Pacific Diabetes Conference

July 23-24, 2018

Global Meeting on Diabetes and Endocrinology

Kuala Lumpur, Malaysia
August 20-21, 2018

28th World Congress on Diabetes, Obesity & Heart

Tokyo, Japan
September 03-04, 2018

2nd International Conference on Thyroid and Pregnancy

Auckland, New Zealand
September 3-4, 2018

11th World Congress on Endocrinology and Metabolic Disorders

Auckland, New Zealand
September 13-15, 2018

26th International Diabetes and Healthcare Conference

Bucharest, Romania
Sep 14-15, 2018

World Congress on Endocrinology

Prague , Czech Republic
Sep 14-15, 2018

Euro Diabetes Congress & Expo

| Prague, Czech Republic
September 28-29, 2018

2nd International Conference on Diabetes and Diabetic Nursing Care

Montreal, Quebec, Canada
November 26-27, 2018

13th European Diabetes and Endocrinology Congress

Dublin, Ireland

Biomarkers for Diabetes Conference Speakers